SUMMARY Tuberculosis associated with systemic lupus erythematosus (SLE) was studied in a cohort of 311 patients seen between 1963 to 1979. There were 16 such patients, giving rise to a prevalence rate of 5 %. The characteristics of SLE-associated tuberculosis include a high incidence of miliary and far-advanced pulmonary disease, delay in establishing diagnosis, especially the extrapulmonary form, and tendency to attribute symptoms like fever, malaise, and weight loss to the lupus process. Treatment was successful in 9 patients. Of the 7 deaths 5 were attributed directly to the mycobacterial infection and 2 to complications of SLE.
In spite of an increased incidence of infection an association between tuberculosis and systemic lupus erythematosus (SLE) has been noted only infrequently.1-3 The present report describes a systematic review of tuberculous infection in a cohort of 311 patients with SLE undergoing treatment with various immunosuppressive drugs over a period of 16 years from 1963 to 1979.
Materials and methods

PATIENTS
We reviewed the records of 311 patients diagnosed as SLE from 1963 to 1979. All these patients fulfilled at least 4 of the criteria laid down by the American Rheumatism Association. 4 The diagnosis of tuberculosis was made on radiological, bacteriological, and histological grounds.
EVALUATION OF DISEASE ACTIVITY
Clearly there are problems in defining disease activity in such a pleomorphic condition as SLE. Since renal status is one of the basic determinants of prognosis, we have adopted the system of Cameron et al.5 (Table 1) to score disease activity arbitrarily. An added advantage of this system is that some weight is given to nonrenal manifestations as well as renal. Disease activity was expressed on a 7-point scale. A score of 1 or 2 was designated as mild disease and a score of [3] [4] [5] [6] [7] 
SPECTRUM OF TUBERCULOSIS
This is shown in Table 3 . Fever, cough, sputum, haemoptysis, dyspnoea, and weight loss were common in these patients but not invariably present. Some of these symptoms were initially attributed to the SLE itself. Seven of the patients (44 %) developed tuberculosis within the first 12 months of therapy for SLE. Nine patients (57%) developed tuberculosis within the first 2 years of therapy. With the exception of 1 case (no. 7) who had haemoptysis 2 years prior to development of active radiological lesion, diagnosis of tuberculosis was established within 3 months of onset of symptoms. This was done with radiology and/or sputum examination and culture in 14 cases. In case 5 the diagnosis was reached only at laparotomy, and in case 15 lymph node biopsy confirmed the diagnosis. In case 6 tuberculous osteomyelitis was confirmed by exploration of the left hip, though the chest radiograph also revealed a soft opacity suggestive of minimal tuberculosis.
RESULTS OF THERAPY
All patients were started on antituberculous therapy immediately on confirmation of diagnosis. All who completed chemotherapy had shown both radiological clearing and bacteriological conversion. Side effects of chemotherapy were infrequent and necessitated change of drug in only 1 patient (case 9). Of the 16 patients 7 died, giving a total mortality of 44%. Two patients died as result of complications of SLE, I of uraemia, and 1 of infection. Five patients (31 %) died directly as result of tuberculosis. These patients had either very advanced cavitating pulmonary disease or miliary spread. Duration of treatment for this group varied from less than 1 month to 12 months.
EFFECT OF DISEASE ACTIVITY AND STEROID THERAPY
The number of tuberculous patients in relation to disease activity and steroid therapy is shown in Table 4 . Eleven patients developed tuberculosis while their SLE was moderately severe or severe P=prednisolone. E=cyclophosphamide (Endoxan).
BP=blood pressure.
GIT=gastrointestinal tract.
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